Balyasny Asset Management’s BridgeBio Pharma BBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $70.9M | Buy |
1,641,620
+841,545
| +105% | +$36.3M | 0.11% | 181 |
|
|
2025
Q1 | $27.7M | Buy |
+800,075
| New | +$27.7M | 0.05% | 363 |
|
|
2024
Q4 | – | Sell |
-518,806
| Closed | -$13.2M | – | 1930 |
|
|
2024
Q3 | $13.2M | Buy |
518,806
+311,526
| +150% | +$7.93M | 0.02% | 584 |
|
|
2024
Q2 | $5.25M | Buy |
+207,280
| New | +$5.25M | 0.01% | 802 |
|
|
2023
Q2 | – | Sell |
-220,090
| Closed | -$3.65M | – | 1865 |
|
|
2023
Q1 | $3.65M | Buy |
+220,090
| New | +$3.65M | 0.01% | 896 |
|
|
2022
Q4 | – | Hold |
0
| – | – | – | 2326 |
|
|
2022
Q3 | – | Hold |
0
| – | – | – | 2354 |
|
|
2022
Q2 | – | Sell |
-36,786
| Closed | -$373K | – | 2292 |
|
|
2022
Q1 | $373K | Buy |
+36,786
| New | +$373K | ﹤0.01% | 1529 |
|
|
2021
Q4 | – | Hold |
0
| – | – | – | 1990 |
|
|
2021
Q1 | – | Hold |
0
| – | – | – | 1566 |
|
|
2020
Q4 | – | Hold |
0
| – | – | – | 1156 |
|